Evidence map›Paper›PMID 39309823›Full record

ArticleHeliyon2024

Divine noni's protective impact on Swiss albino mice's short-term memory impairment caused by cyclophosphamide: A behavioral and biochemical approach.

Mohammad Ali, Shahid Ud Din Wani, S N Manjula, K Mruthunjaya, Faiyaz Shakeel, Bharathi Dr, Sathvik B Sridhar, Ishfaq Mohiuddin, Reyaz Hassan Mir, Tathagata Dey

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mohammad AliDepartment of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, 570015, India.
Shahid Ud Din WaniDepartment of Pharmaceutical Sciences, School of Applied Science and Technology, University of Kashmir, Srinagar, 190006, India.
S N ManjulaDepartment of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, 570015, India.
K MruthunjayaDepartment of Pharmacognosy, JSS College of Pharmacy, JSS Academy of Higher, Education and Research, Mysuru, 570015, India.
Faiyaz ShakeelDepartment of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.
Bharathi DrDepartment of Pharmacology, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B. G Nagar, Bellur, Karnataka, 571418, India.
Sathvik B SridharDepartment of Clinical Pharmacy and Pharmacology, RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah, PO Box, 11172, United Arab Emirates.
Ishfaq MohiuddinDepartment of Zoology, Annamalai University, Annamalainagar, 608002, India.
Reyaz Hassan MirDepartment of Pharmaceutical Sciences, School of Applied Science and Technology, University of Kashmir, Srinagar, 190006, India.
Tathagata DeyDepartment of Pharmaceutical Chemistry, East Point College of Pharmacy, Bangalore, 560049, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclophosphamide (CYL) is a first-line cancer chemotherapeutic agent widely used for the treatment of cancer that has severe toxic effects. The primary mechanism by which CYL induces toxicity through free radical generation.

Indexed as

AntioxidantCyclophosphamideMemory impairmentNoniOxidative stress

Identifiers

PMID39309823
PMCPMC11415706

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.